NCT05847686View on ClinicalTrials.gov

Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

April 8, 2024

Study Completion Date

October 17, 2024

Conditions
Hematopoietic and Lymphatic System NeoplasmMetastatic Malignant Solid Neoplasm
Interventions
OTHER

Counseling

Participate in therapy visits

DRUG

Psilocybin

Given PO

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

Steven & Alexandra Cohen Foundation

OTHER

lead

University of Washington

OTHER